BMC Neurology
(Oct 2021)
Correction to: FXTAS is difficult to differentiate from neuronal intranuclear inclusion disease through skin biopsy: a case report
- Megumi Toko,
- Tomohiko Ohshita,
- Takashi Kurashige,
- Hiroyuki Morino,
- Kodai Kume,
- Hiroshi Yamashita,
- Gen Sobue,
- Yasushi Iwasaki,
- Jun Sone,
- Hideshi Kawakami,
- Hirofumi Maruyama
Affiliations
- Megumi Toko
- Department of Neurology, Hiroshima City Asa Citizens Hospital
- Tomohiko Ohshita
- Department of Neurology, Hiroshima City Asa Citizens Hospital
- Takashi Kurashige
- Department of Neurology, National Hospital Organization Kure Medical Center and Chugoku Caner Center
- Hiroyuki Morino
- Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences
- Kodai Kume
- Department of Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University
- Hiroshi Yamashita
- Department of Neurology, Hiroshima City Asa Citizens Hospital
- Gen Sobue
- Aichi Medical University
- Yasushi Iwasaki
- Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University
- Jun Sone
- Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University
- Hideshi Kawakami
- Department of Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University
- Hirofumi Maruyama
- Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences
- DOI
-
https://doi.org/10.1186/s12883-021-02452-w
- Journal volume & issue
-
Vol. 21,
no. 1
pp.
1
– 1
Abstract
Read online
An amendment to this paper has been published and can be accessed via the original article.
WeChat QR code
